Related references
Note: Only part of the references are listed.Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia
Fatima Akdim et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis
Yingmei Feng et al.
CARDIOVASCULAR RESEARCH (2010)
Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
APOC3 deficiency: from mice to man
Marten H. Hofker
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia
Maartje E. Visser et al.
JOURNAL OF LIPID RESEARCH (2010)
Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy
Fatima Akdim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2010)
Long-term Physiologically Regulated Expression of the Low-density Lipoprotein Receptor In Vivo Using Genomic DNA Mini-gene Constructs
Olivia C. Hibbitt et al.
MOLECULAR THERAPY (2010)
The Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in Macaques
Lili Wang et al.
MOLECULAR THERAPY (2010)
Systematic Evaluation of AAV Vectors for Liver-directed Gene Transfer in Murine Models
Lili Wang et al.
MOLECULAR THERAPY (2010)
New Therapeutic Approaches to Mendelian Disorders
Harry C. Dietz
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis
Sadik H. Kassim et al.
PLOS ONE (2010)
High-density lipoproteins and cardiovascular disease: 2010 update
Khalid Alwaili et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano
Eric T. Alexander et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
Federico Mingozzi et al.
BLOOD (2009)
Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review
Amit R. Rahalkar et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2009)
Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions
E. Van Craeyveld et al.
GENE THERAPY (2009)
Role of Endothelial Lipase in Plasma HDL levels in a Murine Model of Hypertriglyceridemia
Hanayo Tanaka et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Safe and Sustained Overexpression of Functional Apolipoprotein A-I/High-density Lipoprotein in Apolipoprotein A-I-null Mice by Muscular Adeno-associated Viral Serotype 8 Vector Gene Transfer
Giovanni Cimmino et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-choteslerol levels: correction of murine ApoA-I deficiency
Stefan F. C. Vaessen et al.
JOURNAL OF GENE MEDICINE (2009)
Plasma lipoproteins: genetic influences and clinical implications
Robert A. Hegele
NATURE REVIEWS GENETICS (2009)
Lecithin: cholesterol acyltransferase - from biochemistry to role in cardiovascular disease
Xavier Rousset et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia
Daniel M. Kolansky et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients
Erik S. Stroes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Knockdown of Acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice
Ying Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Effect of ABCA1 Mutations on Risk for Myocardial Infarction
Iulia Iatan et al.
CURRENT ATHEROSCLEROSIS REPORTS (2008)
Clinical significance of apolipoprotein A5
E. Shyong Tai et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7)
Vanessa Evans et al.
HUMAN GENE THERAPY (2008)
Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic
Jeffery C. Giering et al.
MOLECULAR THERAPY (2008)
Self-complementary AAV vectors; Advances and applications
Douglas M. McCarty
MOLECULAR THERAPY (2008)
Translating molecular discoveries into new therapies for atherosclerosis
Daniel J. Rader et al.
NATURE (2008)
Abetalipoproteinemia: two case reports and literature review
Rola Zamel et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Rapid regression of atherosclerosis: insights from the clinical and experimental literature
Kevin Jon Williams et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia
Miklos Peterfy et al.
NATURE GENETICS (2007)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Immune response to helper dependent adenoviral mediated liver gene therapy: Challenges and prospects
Michael P. Seiler et al.
CURRENT GENE THERAPY (2007)
ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice
Emanuela Signori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
Xun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection
Olivia C. Hibbitt et al.
JOURNAL OF GENE MEDICINE (2007)
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
Corinna Lebherz et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Update on dyslipidemia
Abhimanyu Garg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons
Anne P. Beigneux et al.
CELL METABOLISM (2007)
Genetic factors affecting HDL levels, structure, metabolism and function
Dmitri Sviridov et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Molecular regulation of HDL metabolism and function: implications for novel therapies
Daniel J. Rader
JOURNAL OF CLINICAL INVESTIGATION (2006)
ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis
Charles W. Joyce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A systematic review of LDL apheresis in the treatment of cardiovascular disease
Jeff Thompsen et al.
ATHEROSCLEROSIS (2006)
Overexpression of apolipoprotein AV in the liver reduces plasma triglyceride and cholesterol but not HDL in ApoE deficient mice
Wei Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Dirk Grimm et al.
NATURE (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation
Colin J. D. Ross et al.
HUMAN GENE THERAPY (2006)
Persistent liver expression of murine apoA-1 using vectors based on adeno-associated viral vectors serotypes 5 and 1
K Kitajima et al.
ATHEROSCLEROSIS (2006)
SiRNA - Gettling the message out
SH Lee et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A spectrum of PCSK9 Alleles contributes to plasma levels of low-density lipoprotein cholesterol
IK Kotowski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery
S-D Li et al.
GENE THERAPY (2006)
Long-term effects of LDL apheresis in patients with severe hypercholesterolemia
BS Sachais et al.
JOURNAL OF CLINICAL APHERESIS (2005)
Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation
RE Moore et al.
CIRCULATION RESEARCH (2005)
Gene therapy for lipoprotein disorders
UC Broedl et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice
XX Yu et al.
HEPATOLOGY (2005)
AAV serotype-dependent apolipoprotein A-IMilano gene expression
BG Sharifi et al.
ATHEROSCLEROSIS (2005)
Antisense oligonucleotides as therapeutics for hyperlipidaemias
RM Crooke
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
New recombinant serotypes of AAV vectors
GP Gao et al.
CURRENT GENE THERAPY (2005)
An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis
RM Crooke et al.
JOURNAL OF LIPID RESEARCH (2005)
Assembly and function of RNA silencing complexes
EJ Sontheimer
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy
HM Kankkonen et al.
MOLECULAR THERAPY (2004)
Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice
L Pastore et al.
GENE (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia
C Lebherz et al.
JOURNAL OF GENE MEDICINE (2004)
Clades of Adeno-associated viruses are widely disseminated in human tissues
GP Gao et al.
JOURNAL OF VIROLOGY (2004)
Progress in antisense technology
ST Crooke
ANNUAL REVIEW OF MEDICINE (2004)
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
MJ Blankinship et al.
MOLECULAR THERAPY (2004)
Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia
S Nomura et al.
GENE THERAPY (2004)
Liver gene therapy: advances and hurdles
TH Nguyen et al.
GENE THERAPY (2004)
Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor
RE Moore et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1
CL Wellington et al.
JOURNAL OF LIPID RESEARCH (2003)
Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia
LM Belalcazar et al.
CIRCULATION (2003)
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
DJ Rader et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
Adeno-associated viruses undergo substantial evolution in primates during natural infections
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice - LCAT gene transfer decreases atherosclerosis
A Mertens et al.
CIRCULATION (2003)
Inhibition of endothelial lipase causes increases HDL cholesterol levels in vivo
WJ Jin et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Endothelial lipase is a major determinant of HDL level
T Ishida et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Recombinant apolipoprotein A-I-Milano: a novel agent for the induction of regression of atherosclerotic plaques
G Chiesa et al.
ANNALS OF MEDICINE (2003)
Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice
HN van der Vliet et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages
RJ Aiello et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Mouse models of atherosclerosis
A Daugherty
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2002)
Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector
IH Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing
LA Pennacchio et al.
SCIENCE (2001)
Surgical management of dyslipidemia: Clinical and experimental evidence
MH Moghadasian et al.
JOURNAL OF INVESTIGATIVE SURGERY (2001)
Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E
RK Tangirala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors
HJ Chao et al.
MOLECULAR THERAPY (2000)
Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice
T Athanasopulos et al.
HUMAN MOLECULAR GENETICS (2000)
Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor
SJ Chen et al.
MOLECULAR THERAPY (2000)
Complete genomic sequence of the human ABCA1 gene:: Analysis of the human and mouse ATP-binding cassette A promoter
S Santamarina-Fojo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat
SJ Smith et al.
NATURE GENETICS (2000)
Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass
M López-Santamaria et al.
JOURNAL OF PEDIATRIC SURGERY (2000)
Phenotypic correction of feline lipoprotein lipase deficiency by adenoviral gene transfer
GQ Lu et al.
HUMAN GENE THERAPY (2000)
Share Paper
